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nderstanding Radiation-
nduced Vascular Disease*
eal L. Weintraub, MD,†§ W. Keith Jones, PHD,‡
avid Manka, PHD†
incinnati, Ohio
adiation injury of blood vessels was originally described
ore than a century ago and remains a contemporary
linical problem, despite dramatic advances in the field of
adiation oncology (1). Clinical studies indicate that pa-
ients who have previously undergone radiation therapy for
arious malignancies—such as lymphoma, breast cancer,
nd head and neck cancer—are at increased risk for devel-
ping vascular disease (2). The consequences are significant;
epending upon the study, the relative risk of suffering a
linical cardiovascular event (i.e., myocardial infarction,
troke) related to radiation therapy ranges from approxi-
ately 1.5- to 4.0-fold, and this risk is further amplified in
he presence of traditional cardiovascular risk factors (3,4).
See page 1227
ost cardiovascular events occur 10 years after complet-
ng radiotherapy, so demonstrating causality has proven
ifficult (5). An estimated 50 million cancer survivors
orldwide have been treated with radiation therapy; accord-
ngly, clinicians must be aware of the potential cardiovas-
ular risk and manage risk factors appropriately. Moreover,
esearch into the mechanisms of radiation-induced vascular
isease is paramount to understanding and potentially
odifying the disease process. The study by Martin et al. (6)
n this issue of the Journal is welcome, because it sheds new
ight on the pathogenesis of radiation-induced vascular
isease in humans.
Experimental studies in animals have firmly established a
ausal relationship between irradiation and vascular disease.
ethal total-body irradiation of atherosclerosis-prone mice
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ational Institutes of Health and the National Institute of Child Health And Human
evelopment.ollowed by bone marrow transplantation noticeably altered
esion composition and stability (7,8). Nonlethal irradiation
f atherosclerosis-prone mice did not change systemic
ndicators of inflammation or cholesterol levels but dramat-
cally altered lesion composition long after treatment (9).
here were no changes in the atherosclerotic lesions of
out-of-field” arteries, consistent with a local rather than
ystemic effect of radiation. Irradiated arteries 22 to 34
eeks after treatment were highly enriched with macro-
hages, which accounted for the majority of the lesion area.
lso, intraplaque hemorrhage was restricted to and com-
only observed in irradiated arteries. These studies, how-
ver, did not identify a molecular mechanism to explain the
bservations.
Studies to address radiation-induced vascular disease in
umans have largely been descriptive in nature. From the
istological perspective, lesions in medium-sized to large
essels (100 m in diameter) exhibit typical features of
therosclerosis, including lipid accumulation, inflammation,
nd thrombosis (3). Increases in intimal thickness and
onnective tissue content are also prominent features (2).
rom the angiographic perspective, the lesions are longer
han traditional atherosclerotic lesions, and the regions of
aximal stenosis tend to be at the ends of the lesions (10).
reating these lesions via open surgical procedures is often
roblematic, due to extensive soft tissue scarring; hence,
ercutaneous approaches are usually preferred (5).
How does a course of radiotherapy initiate a chronic
ascular process that eventually leads to clinical events many
ears after treatment? Experimental studies in vitro and in
ivo indicate that radiation therapy causes acute up-
egulation of pro-inflammatory cytokines and adhesion
olecules in endothelium that recruits inflammatory cells to
ites of vascular injury (11). It is unlikely, however, that this
cute insult per se is sufficient to produce long-term occlu-
ive atherosclerotic disease. Thus, late effects of radiation
herapy are more likely responsible. In this regard, induction
f chronic oxidative stress is increasingly being implicated in
adiation-induced late tissue injury (12). In addition to the
apid burst of free radicals produced acutely by ionization of
ater molecules, radiation increases chronic free radical
roduction and oxidative stress in the affected tissues.
xidative stress up-regulates numerous pathways pertinent
o vascular disease, including matrix metalloproteinases,
dhesion molecules, pro-inflammatory cytokines, and
mooth muscle cell proliferation and apoptosis, while inac-
ivating vasculoprotective nitric oxide. Considerable evi-
ence suggests that the nuclear transcription factor NF-B
erves as a molecular link between oxidative stress and
hronic inflammation (13).
The nuclear factor-kappa B (NF-B) family of transcrip-
ion factors includes 5 members: p50, p52, p65, RelB, and
-Rel. The NF-B is involved in numerous pathological
nd physiological conditions, including cellular function
i.e., proliferation, differentiation, and survival), tumorigen-
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Radiation-Induced Vascular Disease March 23, 2010:1237–9sis, and inflammation. Upon activation, NF-B is released
rom its inhibitory association with the IB proteins in the
ytoplasm and translocates to the nucleus. In the nucleus,
F-B binding to specific deoxyribonucleic acid response
lements initiates robust transcriptional responses and re-
rograms cellular function. Depending upon the stimuli,
F-B can activate distinct sets of downstream genes that
ediate different outcomes (14). In the context of vascular
iology, NF-B is a master regulator of inflammation and
eukocyte adhesion and synchronizes the expression of
dhesion molecules, cytokines, and chemokines in endothe-
ial cells. Importantly, NF-B is controlled by redox regu-
ation, making it a prime candidate to link chronic oxidative
tress to activation of downstream inflammatory pathways
n radiation injury.
The study by Martin et al. (6) provides the first direct
vidence that NF-B is chronically up-regulated in human
rteries after radiation exposure. The investigators examined
aired arterial specimens from skin flaps of patients who had
ndergone irradiation therapy for head-and-neck cancer
etween 4 and 500 weeks previously. They directly com-
ared irradiated versus nonirradiated arteries from the same
atients, thereby avoiding confounding inter-patient vari-
bles. Differentially expressed genes in the irradiated arteries
ere detected with oligonucleotide microarrays, and the
ata were validated by real-time polymerase chain reaction.
hese data were used to detect clusters of altered gene
xpression, which demonstrated patterns consistent with
p-regulated inflammation, coagulation, and angiogenesis.
mportantly, the pattern of altered gene expression in the
rradiated arteries suggested transcriptional regulation by
F-B. Indeed, immunohistological studies demonstrated
p-regulated NF-B in vascular wall cells, with specific
ocalization to macrophages. Interestingly, a group of puta-
ive NF-B–dependent genes were found to be similarly
ysregulated, regardless of the amount of time since irradi-
tion (4 to 7 weeks vs. 20 to 500 weeks). A similar study
ith larger number of patients would be needed to separate
arly-stage from late-stage gene expression programs, which
ight be highly informative.
The study by Martin et al. (6) provides the foundation for
molecular mechanism to explain the effects of radiation on
ascular biology (Fig. 1). As with many studies that address
poorly understood phenomenon, the data generate more
uestions than answers. Are the results observed in the small
onduit arteries in this study translatable to large arteries
hat produce most cardiovascular events? Does oxidative
tress cause the persistent NF-B up-regulation and repro-
ramming of gene expression in irradiated blood vessels?
astly and most importantly, could modulation of NF-B
meliorate the disease process? Several commonly used
gents, such as aspirin, omega-3 fatty acids, and statins,
irectly or indirectly modulate NF-B activity; whether
hese medications could ameliorate radiation-induced vas-
ular disease remains to be determined. Also, inhibitors of
F-B are being tested for a variety of inflammatory states
End might eventually make their way into clinical medicine
13,14). Perhaps such therapy could be employed to treat
adiation-induced vascular disease. Alternatively, the path-
ays responsible for up-regulated oxidative stress might be
argeted. In this regard, activation of the angiotensin II-
ldosterone system has been hypothesized to play a key role
n propagating oxidative stress after radiation therapy
12,15). Thus, pharmacotherapy directed against this path-
ay could potentially be efficacious against radiation-
nduced vascular disease.
In conclusion, Martin et al. (6) have made an important
ontribution to the field of radiation-induced vascular disease
y demonstrating local and sustained up-regulation of NF-B
n irradiated human blood vessels. The expression profiles
uggest that NF-B contributes to the pathology by inducing
ro-inflammatory genes. Further research is needed to deter-
ine the clinical significance of their findings and to investi-
ate whether currently available and/or emerging therapies can
odulate the disease process.
eprint requests and correspondence: Dr. Neal L. Weintraub,
epartment of Internal Medicine, Division of Cardiovascular
iseases, University of Cincinnati College of Medicine, 231
lbert Sabin Way, ML0542, Cincinnati, Ohio 45267-0542.
Figure 1 Proposed Mechanism of Involvement of
NF-B in Radiation-Induced Vascular Disease
NF-B  nuclear factor-kappa B.-mail: neal.weintraub@uc.edu.
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